BioLife Solutions, Inc.
| Nasdaq: BLFS
BioLife Solutions, Inc. designs, manufactures and markets hypothermic storage and cryopreservation solutions for cells, tissues and organs. It also performs contract media manufacturing and contract research and development. The company's proprietary HypoThermosol and CryoStor platform of biopreservation media products are marketed to academic research institutions, hospitals, and commercial companies involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's Good Manufacturing Practices products are serum-free and protein-free, fully defined, and pre-formulated to reduce preservation-induced, delayed-onset cell damage and death. Its enabling technology provides research and clinical customers significantly extended storage stability and improved post-preservation viability and recovery of cells, tissues, and organs. BioLife Solutions was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.